Pharma finance
Medical device CROs: the next growth opportunity?
Medical device clinical trials have increased 63% since 2012 and a market void for mid-size device CROs could present a significant opportunity for growth.
Archives for April 16, 2017
LiveLeaf contracts Emery Pharma to advance next-gen anti-infective drugs
LiveLeaf, Inc. has announced a collaboration with the contract research organization (CRO), Emery Pharma, to advance its development of novel prodrugs for FDA approval.